Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity supports small, short-term clinical trials in humans to gather preliminary data on the effects and feasibility of interventions for disease prevention or treatment relevant to NIDDK's mission. The goal is to establish groundwork for larger, more definitive trials. Applicants should clearly outline their aims and objectives, aiming for results that could advance disease understanding, diagnosis, prevention, or treatment, potentially impacting clinical practice or public…
This Funding Opportunity Announcement encourages the submission ofpilot and feasibilityclinical trialsconducted in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of NIDDK. The program will su…
Source
Grant ID
PAS-23-086
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Program
SBIR
Key Dates
Opportunity Released
March 6, 2023
Open for Submission
February 1, 2023
Submission Deadline
May 7, 2026
Application Window Closes
May 7, 2026
Awards & Funding
Award Ceiling
$200,000
Funding Amount
~$200,000
Similar opportunities
- Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
- NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
- NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
- NIAMS UG3/UH3 Cooperative Agreement for Clinical Trials
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)